Press release
Implantable Neurostimulation Devices Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Emerging Trends
Implantable Neurostimulation Devices Market Size
In the past years, a substantial increase has been observed in the market size of implantable neurostimulation devices. The market which was valued at $8.68 billion in 2024 is projected to rise to $9.64 billion in 2025 boasting a compound annual growth rate (CAGR) of 11.1%. A surge in the demand for non-pharmacological treatments, an increase in the advocacy for less invasive procedures, a growing aged population, an escalating number of psychiatric disorders and a rising prevalence of chronic diseases are some reasons that have fueled the growth in the past period.
Predictions for the implantable neurostimulation devices market indicate that it will witness a substantial increase in the coming years. The market is estimated to reach $14.53 billion by 2029, with a compound annual growth rate (CAGR) of 10.8%. Factors contributing to this projected growth during the forecast period include an uptick in neurological disorders, the burgeoning of lifestyle diseases, enhanced awareness, a climb in spinal cord injuries, and a surge in healthcare spending. Trend highlights for the same period reflect sensing technology, advancements in neurostimulation technologies, technologically sophisticated products, the incorporation of closed-loop systems, and the inclusion of wireless technology.
What Factors Are Propelling the Expansion of the Implantable Neurostimulation Devices Market?
The implantable neurostimulation device market is forecasted to grow due to the increasing occurrence of neurological disorders. Neurological disorders are any conditions that impact the structure or function of the nervous system, leading to a range of symptoms like paralysis, seizures, and cognitive impairments. Greater exposure to risk factors such as high blood pressure, developmental abnormalities, trauma, or injury results in increased detection rates of these disorders. Implantable neurostimulation devices, which are utilized when other treatments are not sufficient or effective, adjust nerve activity and alleviate symptoms. For example, the Alzheimer's Association, a US-based voluntary health organization, estimates that by 2024, 6.9 million Americans aged 65 and older will be living with Alzheimer's disease, 73% of whom are set to be age 75 or older. By 2050, this figure is expected to rise to 12.7 million. As a result, the escalating prevalence of neurological disorders is set to fuel the growth of the implantable neurostimulation device market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19520&type=smp
Which Businesses Are at the Forefront of Implantable Neurostimulation Devices Market Development?
Major companies operating in the implantable neurostimulation devices market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Dignity Health, St. Jude Medical LLC, LivaNova PLC, Nevro Corp., Axonics Inc., NeuroPace Inc., Bioness Inc., Saluda Medical Pty Ltd., SceneRay Co. Ltd., NeuroMetrix Inc., CURE Epilepsy, Synapse Biomedical Inc., NeuroSigma Inc., Nuvectra Corporation, MicroTransponder Inc., Pain Management NYC, Curonix LLC
What Are the Latest Innovations in the Implantable Neurostimulation Devices Market?
Market leaders in the implantable neurostimulation devices segment are prioritizing the creation of technologically upgraded products, such as spinal cord stimulation (SCS) systems, to provide relief from chronic pain. The function of a spinal cord stimulation (SCS) system is to use electrical impulses to regulate nerve activities in the spinal cord, which is effective in alleviating chronic pain and enhancing the quality of life when other treatments fail. For example, Abbott, a medical device firm based in the US, made public its approval from the U.S. Food and Drug Administration (FDA) for the Eterna spinal cord stimulation (SCS) system in December 2022. The smallest implantable, rechargeable spinal cord stimulator in the market, Eterna SCS, has been designed for maximum comfort throughout the day. It is equipped with Abbott's exclusive BurstDR stimulation technology which imitates natural brain firing patterns for superior pain control and it is favored by 87% of patients over the traditional sensation of tingling. Its recharging needs are the least in the market, potentially requiring only five recharges each year because of Xtend energy technology, making Eterna highly convenient. The TotalScan technology makes full-body MRI scans possible and it is adaptable to future innovative developments without needing replacement. Moreover, Abbott has inbuilt mobile application integration that allows patients to monitor battery life and charging status in real time on iPhone devices.
How Is the Implantable Neurostimulation Devices Market Segmented?
The implantable neurostimulation devicesmarket covered in this report is segmented -
1) By Type: Spinal Cord Stimulation (SCS), Gastric Electric Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS), Vagus Nerve Stimulation (VNS), Other Types
2) By Application: Pain Management, Parkinson's Disease, Urinary And Fecal Incontinence, Epilepsy, Gastroparesis, Other Applications
3) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers
Subsegments:
1) By Spinal Cord Stimulation (SCS): Rechargeable SCS Devices, Non-Rechargeable SCS Devices
2) By Gastric Electric Stimulation (GES): Implantable Gastric Stimulators, Adjustable Gastric Stimulators
3) By Deep Brain Stimulation (DBS): DBS Devices for Movement Disorders, DBS Devices for Psychiatric Disorders
4) By Sacral Nerve Stimulation (SNS): SNS Devices for Urinary Incontinence, SNS Devices for Fecal Incontinence
5) By Vagus Nerve Stimulation (VNS): VNS Devices for Epilepsy, VNS Devices for Depression
6) By Other Types: Peripheral Nerve Stimulation (PNS), Cortical Stimulation Devices, Novel Neurostimulation Technologies
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/implantable-neurostimulation-devices-global-market-report
Where Is the Implantable Neurostimulation Devices Market Growth Most Prominent?
North America was the largest region in the implantable neurostimulation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable neurostimulation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The Implantable Neurostimulation Devices Global Market Report?
- Market Size Analysis: Analyze the Implantable Neurostimulation Devices Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Implantable Neurostimulation Devices Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Implantable Neurostimulation Devices Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Implantable Neurostimulation Devices Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19520
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Implantable Neurostimulation Devices Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Emerging Trends here
News-ID: 3869020 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Devices
Spinal Fusion Devices Market Size to Reach Valuation of $7.43 Billion by 2022 | …
Increase in adoption of minimally invasive spine surgery (MISS) presents lucrative opportunities for key players in the spinal fusion devices market. MISS is preferred to conventional techniques, owing to its associated benefits such as minimal cut or incision, which in turn reduces the chances of damage caused to the adjacent muscles.
Spinal fusion devices market was valued at $5,867 million in 2015, and is projected to reach $7,435 million by 2022,…
Global Beauty Devices Market Industry Insights Forecast to 2024, Coverage Cellul …
The global beauty devices market was valued at USD 39.1 billion in 2018 and is anticipated to grow at a CAGR of 18.4% during the forecast period. The significant growth in the beauty devices industry is imputed to the rise in prevalence of skin disorders, increasing rate of hormonal imbalance cases, an increase in the geriatric population, and growing awareness for beauty devices.
Request for Free Sample Copy of this Research…
Canada Anesthesia and Respiratory Devices Market Segments Including Airway Manag …
ReportsnReports added a new report on The Canada Anesthesia and Respiratory Devices Market report that delivers the clean elaborated structure of the Report comprising each and every business-related information of the market at a global level. The in-depth study on the current state which focuses on the major drivers and restraints for the key players. Canada Anesthesia and Respiratory Devices Market Industry research report provides granular analysis of the market…
Global Beauty Devices Market Insights 2018 By Products Hair Growth Devices,Acne …
Description
This report studies the global market size of Beauty Devices in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Beauty Devices in these regions.
This research report categorizes the global Beauty Devices market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers,…
Wearable Electronic Devices Market,Wearable Electronic Devices Industry, Global …
Latest industry research report on: Global Wearable Electronic Devices Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts
This report studies the global Wearable Electronic Devices market status and forecast, categorizes the global Wearable Electronic Devices market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in United States, Europe, China, Japan, South Korea and Taiwan and other…
Ophthalmic Devices Market By Product Function [Ophthalmic Surgery Devices (Refra …
Ophthalmology is a branch of medical sciences that deals with the structure, function, and various eye diseases. The ophthalmic devices are medical equipment designed for diagnosis, surgical, and vision correction purposes. These devices gain increased importance and adoption due to high prevalence of various ophthalmic diseases such as glaucoma, cataract, and other vision related issues.
Request Sample At: https://www.bigmarketresearch.com/request-sample/1074435
Increase in prevalence rate of eye related diseases such as glaucoma, cataract,…
